Bayer to make $10.5 billion push to settle roundup cases, Bloomberg reports

BERLIN, Feb 17 (Reuters) – Bayer is planning to announce a $10.5 billion settlement push to settle current and future cancer lawsuits over its Roundup weedkiller, Bloomberg reported on Tuesday, citing people familiar with the plan.

Bayer did not immediately comment on the report.

The German chemical giant is set to propose a $7.5 billion class-action settlement through cases filed in state court in Missouri designed to resolve Roundup suits that already have been filed and potential claims that could be filed over a 20-year period, Bloomberg reported.

Bayer is also preparing to announce $3 billion in settlements of existing U.S. cases in which former Roundup users blame the herbicide for causing their non-Hodgkins lymphoma, it reported.

The company has paid about $10 billion to settle most of the Roundup lawsuits that were pending as of 2020, but failed to get a settlement covering future cases. New lawsuits have continued to pour in since then. Plaintiffs have said they developed non-Hodgkin’s lymphoma and other forms of cancer due to using Roundup, either at home or on the job.

Roundup, which was acquired by is among the most widely used weedkillers in the United States.

(Additional reporting by Kirsti KnolleWriting by Linda PasquiniEditing by Madeline Chambers)